Rosacea
Rosacea is a chronic inflammatory skin condition primarily affecting the central regions of the face, characterized by redness, flushing, inflamed bumps, visible blood vessels, and sometimes skin thickening, with triggers including sunlight, alcohol, stress, and spicy foods. In severe cases, it can lead to rhinophyma, a condition involving a red, enlarged nose.
Health Outcomes
- Altered Epithelial Plasma Membrane Properties
- Cosmetic Material Identification
- Enhanced Barrier Integrity
- Enhanced Epithelial Cell Migration
- Enhanced Phagocytic Function
- Enhanced Safety in Topical Application
- Enhanced Skin Gloss
- Enhanced Skin Mucus Protease Activity
- Enhanced β-Defensin 3 Activity
- Improved Consumer Acceptability
- Improved Cutaneous Vasoconstriction
- Improved Dermal Health Parameter
- Improved Dermatology Life Quality Index
- Improved Dry Eye Symptoms
- Improved Epithelial Integrity
- Improved Epithelial Protection
- Improved Hyperpigmentation Index
- Improved Inflammatory Skin Condition
- Improved Investigator Global Assessment Score
- Improved Lesion Regression
- Improved Ocular Surface Disease Index
- Improved Physician Global Assessment
- Improved Skin Condition
- Improved Skin Condition Score
- Improved Skin Disease Severity
- Improved Skin Health
- Improved Skin Mucus Lysozyme Activity
- Improved Skin Recovery
- Improved Skin Responses
- Improved Skin Satisfaction
- Improved Skin Symptoms
- Improved Total VISIA Score
- Increased Antimicrobial Peptide LL-37 Level
- Increased Cathelicidin Level
- Increased Expressions of β-Defensins
- Increased Host Defense Peptide Levels
- Increased LL-37 Levels
- Increased Surface Activity
- Maintained Beta-Defensin-2 Level
- Maintained Epithelial Barrier Integrity
- Maintained Epithelium Structure
- Maintained Remission of Skin Symptoms
- Maintained Soft-Tissue Health
- No Adverse Effects
- No Adverse Effects on Body Weight or Food Intake
- No Change in Antibiotic Usage
- No Histological Dysfunction
- No Significant Reduction in Atopic Dermatitis Severity
- Potential Skin Effect
- Reduced Blepharitis Symptoms
- Reduced Burning Intensity
- Reduced Demodex Count
- Reduced Dermal Irritation
- Reduced Dermal Mast Cell Infiltration
- Reduced Erythema
- Reduced Erythema Intensity
- Reduced Facial Skin Pores
- Reduced Flare Area
- Reduced Inflammatory Infiltrate
- Reduced Ocular Inflammation
- Reduced Rash Incidence
- Reduced Red Eye Duration
- Reduced Signs of Aging
- Reduced Skin Complication
- Reduced Skin Inflammation
- Reduced Skin Lesion Area
- Reduced Skin Redness
- Reduced Skin Spot
- Reduced Skin and Eye Irritation
- Reduced Topical Drug Application
- Resolved Lesion
- Stabilized Skin Microbiome
- Unchanged Inflammatory Response